Literature DB >> 29937982

Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor.

Aruna Wijeratne1, Junpeng Xiao1, Christopher Reutter1, Kelly W Furness1, Rebecca Leon1, Mohammad Zia-Ebrahimi1, Rachel N Cavitt1, John M Strelow1, Robert D Van Horn1, Sheng-Bin Peng1, David A Barda1, Thomas A Engler1, Michael J Chalmers1.   

Abstract

The KRASG12C protein product is an attractive, yet challenging, target for small molecule inhibition. One option for therapeutic intervention is to design small molecule ligands capable of binding to and inactivating KRASG12C via formation of a covalent bond to the sulfhydryl group of cysteine 12. In order to better understand the cellular off-target interactions of Compound 1, a covalent KRASG12C inhibitor, we have completed a series of complementary chemical proteomics experiments in H358 cells. A new thiol reactive probe (TRP) was designed and used to construct a cellular target occupancy assay for KRASG12C. In addition, the thiol reactive probes allowed us to profile potential off-target interactions of Compound 1 with over 3200 cysteine residues. In order to complement the TRP data we designed Compound 2, an alkyne containing version of Compound 1, to serve as bait in competitive chemical proteomics experiments. Herein, we describe and compare data from both the TRP and the click chemistry probe pull down experiments.

Entities:  

Year:  2018        PMID: 29937982      PMCID: PMC6004567          DOI: 10.1021/acsmedchemlett.8b00110

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  18 in total

1.  Know your target, know your molecule.

Authors:  Mark E Bunnage; Adam M Gilbert; Lyn H Jones; Erik C Hett
Journal:  Nat Chem Biol       Date:  2015-06       Impact factor: 15.040

Review 2.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

Review 3.  Enzyme inhibitor discovery by activity-based protein profiling.

Authors:  Micah J Niphakis; Benjamin F Cravatt
Journal:  Annu Rev Biochem       Date:  2014       Impact factor: 23.643

4.  Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States.

Authors:  Daniel R Gentile; Manoj K Rathinaswamy; Meredith L Jenkins; Steven M Moss; Braden D Siempelkamp; Adam R Renslo; John E Burke; Kevan M Shokat
Journal:  Cell Chem Biol       Date:  2017-10-12       Impact factor: 8.116

5.  Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor.

Authors:  Sang Min Lim; Kenneth D Westover; Scott B Ficarro; Rane A Harrison; Hwan Geun Choi; Michael E Pacold; Martin Carrasco; John Hunter; Nam Doo Kim; Ting Xie; Taebo Sim; Pasi A Jänne; Matthew Meyerson; Jarrod A Marto; John R Engen; Nathanael S Gray
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-20       Impact factor: 15.336

6.  A Caged Electrophilic Probe for Global Analysis of Cysteine Reactivity in Living Cells.

Authors:  Masahiro Abo; Eranthie Weerapana
Journal:  J Am Chem Soc       Date:  2015-06-01       Impact factor: 15.419

7.  Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity.

Authors:  L A Bateman; T B Nguyen; A M Roberts; D K Miyamoto; W-M Ku; T R Huffman; Y Petri; M J Heslin; C M Contreras; C F Skibola; J A Olzmann; D K Nomura
Journal:  Chem Commun (Camb)       Date:  2017-06-29       Impact factor: 6.222

8.  Ras in cancer and developmental diseases.

Authors:  Alberto Fernández-Medarde; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

9.  Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.

Authors:  Matthew R Janes; Jingchuan Zhang; Lian-Sheng Li; Rasmus Hansen; Ulf Peters; Xin Guo; Yuching Chen; Anjali Babbar; Sarah J Firdaus; Levan Darjania; Jun Feng; Jeffrey H Chen; Shuangwei Li; Shisheng Li; Yun O Long; Carol Thach; Yuan Liu; Ata Zarieh; Tess Ely; Jeff M Kucharski; Linda V Kessler; Tao Wu; Ke Yu; Yi Wang; Yvonne Yao; Xiaohu Deng; Patrick P Zarrinkar; Dirk Brehmer; Dashyant Dhanak; Matthew V Lorenzi; Dana Hu-Lowe; Matthew P Patricelli; Pingda Ren; Yi Liu
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

10.  A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors.

Authors:  Bryan R Lanning; Landon R Whitby; Melissa M Dix; John Douhan; Adam M Gilbert; Erik C Hett; Theodore O Johnson; Chris Joslyn; John C Kath; Sherry Niessen; Lee R Roberts; Mark E Schnute; Chu Wang; Jonathan J Hulce; Baoxian Wei; Laurence O Whiteley; Matthew M Hayward; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2014-07-13       Impact factor: 15.040

View more
  2 in total

Review 1.  Reactive-cysteine profiling for drug discovery.

Authors:  Aaron J Maurais; Eranthie Weerapana
Journal:  Curr Opin Chem Biol       Date:  2019-03-18       Impact factor: 8.822

Review 2.  Chemoproteomic methods for covalent drug discovery.

Authors:  Wai Cheung Chan; Shabnam Sharifzadeh; Sara J Buhrlage; Jarrod A Marto
Journal:  Chem Soc Rev       Date:  2021-08-02       Impact factor: 60.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.